SBWire

The number of kinase inhibitors entering clinical development has increased significantly in recent years. In addition to major pharmaceutical and biotech companies, an increasing number of emerging companies are focusing on their development.

The creation of new animal models is an important part of animal-based therapeutic strategy research. A major reason why the pharmaceutical/biotechnology industry needs new animal models is because poorly predictive animal models are a major cause of drug attrition during development.

The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global oncology biomarkers market to be held on 18th May 2010.

Central America has limited domestic manufacturing and is therefore dependent on pharmaceutical imports. The region’s negative trade balance is forecast to increase from -US$1.21bn in 2009 to - US$2.05bn in 2014. Imports are generally from the US, Western Europe and Mexico.

The focus of this report is on drug/diagnostic combinations -- drugs used to treat patients, and on diagnostic tests that can provide information about how a patient may respond to treatment with that drug.Personalized medicine has emerged as an important field for companies in both the pharmaceutical and diagnostic industries.

ReportsandReports announce it will carry Multiplex Assays: Evolving Technologies, Applications and Future Directions Market Research Report in its Store.

More than 90% of patients diagnosed with liver cancer are between 45 years and 85 years of age. Nexavar is the only available Food and Drug Association (FDA) approved treatment for advanced liver cancer patients.

One in every eight births in the U.S. are preterm, and the condition is on an alarming rise due to factors such as induced fertility, labor treatments, poor prenatal care, inappropriate maternal age, obesity, and smoking.

GlobalData’s report, “Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016” provides key data, information and analysis on the global drug eluting balloons (DEB) market, a key segment within the medical device industyr. The report provides market landscape, competitive landscape and market trends information the drug eluting balloons (DEB) market.

The report identifies the key trends shaping and driving the global HIV/AIDS market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders.

Recent research conducted by scientists at ChemImage Corporation revealed that wide-field Raman Chemical Imaging (RCI) shows promise as an in vitro method for identifying drug particle size distribution of Advair Discus® 500/50, a commercial dry powder inhaler with two active pharmaceutical ingredients.

This report details the various categories of prescription dermatological drugs, describes the global market and identifies major market factors that may help to shape the market for treatments in the future.

This report reviews various biomarker technologies and therapy area applications. Market drivers and restraints are viewed in the context of biomarker activity of leading innovator companies as well as contract research organizations.

The report identifies the key trends shaping and driving the global periodontal disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders.

The report identifies the key trends shaping and driving the global nonalcoholic steatohepatitis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders.

Lifestyle drugs have been a much debated segment of therapeutics for the pharmaceutical industry primarily due to the issues surrounding their inclusion in drug payment plans and diversion of resources for their research.

After an overwhelming response to the Global automotive database released earlier this year, Barcatech has now published the Global Pharmaceutical database 2010. The custom database providers have updated their website with the second edition to their global database series of 2010. Following its predecessor, the Global Pharmaceutical Database lists business contact information of the top 50 Pharmaceutical and healthcare companies from across the world, only this time the database lists more than 5000 business contacts as compared to the 2000 contacts in the global automotive database.

The report identifies the key trends shaping and driving the global osteoarthritis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders.

Katy Spink, Vice President of Operations for Geron, will give the Featured presentation at GTCbio’s 6th Stem Cell Research & Therapeutics Conference, May 27-28, 2010 in Boston, MA.

Personalized Medicine has given the diagnostics field a huge boost in terms of publicity/public attention, revenue potential, and investment interest. Still questions exist as to how extensive such testing will be and how soon we will see its growth in clinical applications.

Kerr Drug, a nationally recognized innovator and provider of pharmacy and other healthcare related services, has signed to underwrite the popular public radio program The People’s Pharmacy. The agreement calls for cross-promotional opportunities between Kerr Drug and The People’s Pharmacy as well as its creators and hosts, Joe and Terry Graedon. Content from the health library of The People’s Pharmacy website as well as podcasts of the radio program will be available on Kerr Drug’s website.

Digging deep beneath the corporate veneer, this three-part documentary exposes the truth behind the slick marketing schemes…

Quality Circle Forum of India (QCFI) is a prominent national professional body promoting and rewarding initiatives that drive total quality

Scientists working with CHO cells can now access an informational online video featuring a presentation by Dr. Steve Pettit, InVitria’s Director of Cell Culture Product Development.

This analysis examines the historical and forecast performance for Allergan in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.